首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1071113篇
  免费   77722篇
  国内免费   2343篇
耳鼻咽喉   15538篇
儿科学   32129篇
妇产科学   30882篇
基础医学   151891篇
口腔科学   31468篇
临床医学   93372篇
内科学   202057篇
皮肤病学   21678篇
神经病学   83171篇
特种医学   45998篇
外国民族医学   259篇
外科学   167875篇
综合类   26193篇
现状与发展   2篇
一般理论   301篇
预防医学   85951篇
眼科学   25019篇
药学   79157篇
  2篇
中国医学   1761篇
肿瘤学   56474篇
  2018年   11292篇
  2017年   10013篇
  2016年   10109篇
  2015年   13009篇
  2014年   16095篇
  2013年   21248篇
  2012年   34040篇
  2011年   30237篇
  2010年   17090篇
  2009年   17798篇
  2008年   26325篇
  2007年   29196篇
  2006年   29188篇
  2005年   36508篇
  2004年   37463篇
  2003年   32301篇
  2002年   26668篇
  2001年   40185篇
  2000年   38553篇
  1999年   36488篇
  1998年   10073篇
  1997年   9094篇
  1996年   9077篇
  1992年   33166篇
  1991年   32805篇
  1990年   32525篇
  1989年   31239篇
  1988年   29330篇
  1987年   28801篇
  1986年   27306篇
  1985年   26066篇
  1984年   19885篇
  1983年   16778篇
  1982年   9874篇
  1981年   9016篇
  1980年   8543篇
  1979年   20269篇
  1978年   14343篇
  1977年   11854篇
  1976年   10868篇
  1975年   12483篇
  1974年   15590篇
  1973年   14796篇
  1972年   14165篇
  1971年   13307篇
  1970年   12680篇
  1969年   12239篇
  1968年   11061篇
  1967年   10316篇
  1966年   9521篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
42.
43.
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma  相似文献   
44.
45.

Objective

Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.

Methods

From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.

Results

Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).

Conclusions

Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes.  相似文献   
46.
47.
48.
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号